It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile

-or-

call (888) 352-RUSH for help arranging an appointment

Mehmet Kocak, MD

Specialty:
  • Neuroradiology
  • Diagnostic Radiology
  • Nuclear Medicine
Board Certification:
  • Neuroradiology
  • Diagnostic Radiology
Faculty Rank: Associate Professor
Medical or Graduate Education: Istanbul University Faculty of Medicine
Residency: Istanbul University Faculty of Medicine - Nuclear Medicine
  Medical College of Wisconsin - Radiology
Fellowship: Medical College of Wisconsin - Neuroradiology; Nuclear Medicine
Clinical Expertise:
  • Functional MRI
  • Magnetic resonance imaging (MRI)
  • Neuroimaging
  • PET scan
Research Interests:
  • Advanced neurofunctional imaging
Languages Spoken:
  • Turkish
Google Map
  • Affiliated Radiologists, S.C./DBA: Circle Imaging Center
  • Professional Building
  • 1725 W. Harrison St.
  • Suite 437
  • Chicago, IL  60612
  • Phone: (312) 942-5781
  • Fax: (312) 942-2114
  • View Larger MapDriving Directions

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
    Poussaint TY, Vajapeyam S, Ricci KI, Panigrahy A, Kocak M, Kun LE, Boyett JM, Pollack IF, Fouladi M
    Neuro-oncology
    2015 Oct 20
    :.
  2. Recidivism in Liver Transplant Recipients With Alcoholic Liver Disease: Analysis of Demographic, Psychosocial, and Histology Features.
    Satapathy SK, Eason JD, Nair S, Dryn O, Sylvestre PB, Kocak M, Vanatta JM
    Exp Clin Transplant
    2015 Oct
    13(5):430-40.
  3. Metal concentration and antioxidant activity of edible mushrooms from Turkey.
    Sarikurkcu C, Tepe B, Kocak MS, Uren MC
    Food Chem
    2015 May 15
    175:549-55.
  4. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.
    Jakacki RI, Burger PC, Kocak M, Boyett JM, Goldwein J, Mehta M, Packer RJ, Tarbell NJ, Pollack IF
    Pediatr Blood Cancer
    2015 May
    62(5):776-83.
  5. Pediatric brain tumor consortium multisite assessment of apparent diffusion coefficient z-axis variation assessed with an ice-water phantom.
    Mulkern RV, Ricci KI, Vajapeyam S, Chenevert TL, Malyarenko DI, Kocak M, Poussaint TY
    Acad Radiol
    2015 Mar
    22(3):363-9.
  6. Dissemination of the Look AHEAD intensive lifestyle intervention in the United States Air Force: study rationale, design and methods.
    Krukowski RA, Hare ME, Talcott GW, Johnson KC, Richey PA, Kocak M, Balderas J, Colvin L, Keller PL, Waters TM, Klesges RC
    Contemp Clin Trials
    2015 Jan
    40:232-9.
  7. A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.
    Kilburn LB, Kocak M, Decker RL, Wetmore C, Chintagumpala M, Su J, Goldman S, Banerjee A, Gilbertson R, Fouladi M, Kun L, Boyett JM, Blaney SM
    Neuro-oncology
    2015 Feb
    17(2):303-11.
  8. Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.
    Hoffman LM, Fouladi M, Olson J, Daryani VM, Stewart CF, Wetmore C, Kocak M, Onar-Thomas A, Wagner L, Gururangan S, Packer RJ, Blaney SM, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ
    Childs Nerv Syst
    2015 Aug
    31(8):1283-9.
  9. Bone morphology in 46 BXD recombinant inbred strains and femur-tibia correlation.
    Zhang Y, Huang J, Jiao Y, David V, Kocak M, Roan E, Di'Angelo D, Lu L, Hasty KA, Gu W
    ScientificWorldJournal
    2015
    2015:728278.
  10. Association between dietary patterns during pregnancy and birth size measures in a diverse population in Southern US.
    Colón-Ramos U, Racette SB, Ganiban J, Nguyen TG, Kocak M, Carroll KN, Völgyi E, Tylavsky FA
    Nutrients
    2015
    7(2):1318-32.
  11. 18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium.
    Zukotynski K, Fahey F, Kocak M, Kun L, Boyett J, Fouladi M, Vajapeyam S, Treves T, Poussaint TY
    J. Nucl. Med.
    2014 Sep
    55(9):1473-80.
  12. Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34.
    Strother DR, Lafay-Cousin L, Boyett JM, Burger P, Aronin P, Constine L, Duffner P, Kocak M, Kun LE, Horowitz ME, Gajjar A
    Neuro-oncology
    2014 Mar
    16(3):457-65.
  13. Changes in low levels of lead over the course of pregnancy and the association with birth outcomes.
    Rabito FA, Kocak M, Werthmann DW, Tylavsky FA, Palmer CD, Parsons PJ
    Reprod. Toxicol.
    2014 Dec
    50:138-44.
  14. A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium report.
    Su JM, Thompson P, Adesina A, Li XN, Kilburn L, Onar-Thomas A, Kocak M, Chyla B, McKeegan E, Warren KE, Goldman S, Pollack IF, Fouladi M, Chen A, Giranda V, Boyett J, Kun L, Blaney SM
    Neuro-oncology
    2014 Dec
    16(12):1661-8.
  15. Methylation quantitative trait loci (meQTLs) are consistently detected across ancestry, developmental stage, and tissue type.
    Smith AK, Kilaru V, Kocak M, Almli LM, Mercer KB, Ressler KJ, Tylavsky FA, Conneely KN
    BMC Genomics
    2014
    15:145.
  16. Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas.
    Qaddoumi I, Kocak M, Pai Panandiker AS, Armstrong GT, Wetmore C, Crawford JR, Lin T, Boyett JM, Kun LE, Boop FA, Merchant TE, Ellison DW, Gajjar A, Broniscer A
    Front Oncol
    2014
    4:67.
  17. Evaluation of the biodistribution of 11C-methionine in children and young adults.
    Harris SM, Davis JC, Snyder SE, Butch ER, Vavere AL, Kocak M, Shulkin BL
    J. Nucl. Med.
    2013 Nov
    54(11):1902-8.
  18. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.
    Kilburn LB, Kocak M, Schaedeli Stark F, Meneses-Lorente G, Brownstein C, Hussain S, Chintagumpala M, Thompson PA, Gururangan S, Banerjee A, Paulino AC, Kun L, Boyett JM, Blaney SM
    Neuro-oncology
    2013 Jun
    15(6):759-66.
  19. An empirical Bayes approach for analysis of diverse periodic trends in time-course gene expression data.
    Kocak M, George EO, Pyne S, Pounds S
    Bioinformatics
    2013 Jan 15
    29(2):182-8.
  20. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium.
    Zukotynski KA, Fahey FH, Vajapeyam S, Ng SS, Kocak M, Gururangan S, Kun LE, Poussaint TY
    J. Nucl. Med.
    2013 Aug
    54(8):1237-43.
  21. Evaluation of the process of recycling and renal parenchymal injury after eswl with metabolites excreted in the urine.
    Ceylan C, Dogan S, Saydam G, Kocak MZ, Doluoglu OG
    Ren Fail
    2013
    35(4):466-71.
  22. Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).
    Blaney SM, Kocak M, Gajjar A, Chintagumpala M, Merchant T, Kieran M, Pollack IF, Gururangan S, Geyer R, Phillips P, McLendon RE, Packer R, Goldman S, Banerjee A, Heideman R, Boyett JM, Kun L
    J. Neurooncol.
    2012 Sep
    109(3):565-71.
  23. Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007.
    Pui CH, Pei D, Pappo AS, Howard SC, Cheng C, Sandlund JT, Furman WL, Ribeiro RC, Spunt SL, Rubnitz JE, Jeha S, Hudson MM, Kun LE, Merchant TE, Kocak M, Broniscer A, Metzger ML, Downing JR, Leung W, Evans WE, Gajjar A
    J. Clin. Oncol.
    2012 Jun 1
    30(16):2005-12.
  24. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.
    Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, Goldwein J, Mehta M, Packer RJ, Tarbell N, Fitz C, Vezina G, Hilden J, Pollack IF
    J. Clin. Oncol.
    2012 Jul 20
    30(21):2648-53.
  25. Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors.
    Qaddoumi I, Sane M, Li S, Kocak M, Pai-Panandiker A, Harreld J, Klimo P, Wright K, Broniscer A, Gajjar A
    Childs Nerv Syst
    2012 Jul
    28(7):1017-24.
  26. Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.
    Godfraind C, Kaczmarska JM, Kocak M, Dalton J, Wright KD, Sanford RA, Boop FA, Gajjar A, Merchant TE, Ellison DW
    Acta Neuropathol.
    2012 Aug
    124(2):247-57.
  27. A Simulation Based Evaluation of the Asymptotic Power Formulae for Cox Models in Small Sample Cases.
    Kocak M, Onar-Thomas A
    Am Stat
    2012
    66(3):173-179.
  28. Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials.
    Donahue B, Marymont MA, Kessel S, Iandoli MK, Fitzgerald T, Holmes E, Kocak M, Boyett JM, Gajjar A, Packer RJ
    Front Oncol
    2012
    2:185.
  29. Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
    Fouladi M, Stewart CF, Olson J, Wagner LM, Onar-Thomas A, Kocak M, Packer RJ, Goldman S, Gururangan S, Gajjar A, Demuth T, Kun LE, Boyett JM, Gilbertson RJ
    J. Clin. Oncol.
    2011 Sep 10
    29(26):3529-34.
  30. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.
    Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE
    Neuro-oncology
    2011 Mar
    13(3):298-306.
  31. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
    Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, Kenney AM, Brat DJ, Perry A, Yong WH, Taylor RE, Bailey S, Clifford SC, Gilbertson RJ
    Acta Neuropathol.
    2011 Mar
    121(3):381-96.
  32. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.
    Pollack IF, Stewart CF, Kocak M, Poussaint TY, Broniscer A, Banerjee A, Douglas JG, Kun LE, Boyett JM, Geyer JR
    Neuro-oncology
    2011 Mar
    13(3):290-7.
  33. Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
    Zukotynski KA, Fahey FH, Kocak M, Alavi A, Wong TZ, Treves ST, Shulkin BL, Haas-Kogan DA, Geyer JR, Vajapeyam S, Boyett JM, Kun LE, Poussaint TY
    J. Nucl. Med.
    2011 Feb
    52(2):188-95.
  34. Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients.
    Korff A, Pfeiffer B, Smeyne M, Kocak M, Pfeiffer RF, Smeyne RJ
    Parkinsonism Relat. Disord.
    2011 Dec
    17(10):765-8.
  35. Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.
    McLendon RE, Adekunle A, Rajaram V, Koçak M, Blaney SM
    Arch. Pathol. Lab. Med.
    2011 Aug
    135(8):984-93.
  36. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
    Ellison DW, Kocak M, Dalton J, Megahed H, Lusher ME, Ryan SL, Zhao W, Nicholson SL, Taylor RE, Bailey S, Clifford SC
    J. Clin. Oncol.
    2011 Apr 10
    29(11):1400-7.
  37. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
    Poussaint TY, Kocak M, Vajapeyam S, Packer RI, Robertson RL, Geyer R, Haas-Kogan D, Pollack IF, Vezina G, Zimmerman R, Cha S, Patay Z, Boyett JM, Kun LE
    Neuro-oncology
    2011 Apr
    13(4):417-27.
  38. Maximum likelihood estimation of reviewers' acumen in central review setting: categorical data.
    Zhao W, Boyett JM, Kocak M, Ellison DW, Wu Y
    Theor Biol Med Model
    2011
    8:3.
  39. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.
    Ellison DW, Kocak M, Figarella-Branger D, Felice G, Catherine G, Pietsch T, Frappaz D, Massimino M, Grill J, Boyett JM, Grundy RG
    J Negat Results Biomed
    2011
    10:7.
  40. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
    Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Panandiker AP, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A
    J. Clin. Oncol.
    2010 Nov 1
    28(31):4762-8.
  41. A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.
    Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, Blaney SM, Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JM
    Eur. J. Cancer
    2010 Dec
    46(18):3287-93.
  42. Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma.
    Löbel U, Sedlacik J, Sabin ND, Kocak M, Broniscer A, Hillenbrand CM, Patay Z
    Neuroradiology
    2010 Dec
    52(12):1167-77.
  43. Imaging in neurodegenerative disorders.
    Aralasmak A, Kocak M.
    Semin Roentgenol. 2010
    2010 Apr
    45(2):126-36. doi: 10.1053/j.ro.2009.09.009. Review.
  44. Motor homunculus: passive mapping in healthy volunteers by using functional MR imaging--initial results.
    Kocak M, Ulmer JL, Sahin Ugurel M, Gaggl W, Prost RW.
    Radiology. 2009
    2009 May
    251(2):485-92. doi: 10.1148/radiol.2512080231. Epub 2009 Mar 4.
  45. Advanced imaging in paediatric neuroradiology.
    Kocak M.
    Pediatr Radiol. 2009
    2009 Jun
    39 Suppl 3:456-63. doi: 10.1007/s00247-009-1230-9. Review. No abstract available.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript